Define osteoporosis. Describe its causes, pathogenesis and diagnosis.
Definition
Osteoporosis is a skeletal disorder characterised by reduced bone mass and microarchitectural deterioration, with normal mineralisation, leading to increased bone fragility and fracture. The bone is normal in quality but deficient in quantity.
Classification and Causes
| Type | Causes |
|---|---|
| Primary — postmenopausal (type 1) | Oestrogen deficiency; affects trabecular bone predominantly; hence vertebral crush fractures and Colles fracture |
| Primary — senile (type 2) | Age-related; affects cortical and trabecular bone; hence femoral neck fractures |
| Secondary — endocrine | Corticosteroids (the commonest secondary cause), Cushing syndrome, hyperthyroidism, hyperparathyroidism, hypogonadism, diabetes |
| Secondary — nutritional | Calcium and vitamin D deficiency, malabsorption, anorexia nervosa, alcoholism |
| Secondary — other | Immobilisation, rheumatoid arthritis, myeloma, chronic kidney disease, heparin, anticonvulsants, osteogenesis imperfecta |
- Risk factors — mnemonic "shattered": Steroids, Hyperthyroidism and hyperparathyroidism, Alcohol and tobacco, Thin (low body mass index), Testosterone deficiency, Early menopause, Renal or liver failure, Erosive/inflammatory disease, Dietary calcium deficiency or malabsorption
Pathogenesis
Peak bone mass is reached at about 30 years, then declines → Bone is continuously remodelled by osteoclasts (resorption) and osteoblasts (formation) → oestrogen normally restrains osteoclasts by suppressing RANKL and raising osteoprotegerin → At the menopause, oestrogen falls → RANKL rises → osteoclast activity increases → Resorption exceeds formation → Trabeculae thin, perforate and lose connectivity — microarchitecture is lost, not merely mass → Fragility fracture after minimal trauma
CLINICAL PEARL
Osteoporosis is silent until the first fracture, which is exactly why it is dangerous. There is no pain from the bone loss itself. A vertebral crush fracture may be attributed to "old age" and a hip fracture treated as a fall — when the fracture is the disease presenting. Around a fifth of patients die within a year of a hip fracture, which is why case-finding matters.
Diagnosis
- Serum calcium, phosphate and alkaline phosphatase are all normal — the biochemical signature, and what distinguishes it from osteomalacia and hyperparathyroidism
- DEXA (dual-energy X-ray absorptiometry) is the standard: T-score at or below −2.5 = osteoporosis; −1 to −2.5 = osteopenia
- Plain radiographs are insensitive — about 30 to 40% of bone mass must be lost before they show anything
- Investigate for secondary causes in men, in premenopausal women, and where the picture is unusual — myeloma, hyperparathyroidism, thyrotoxicosis, coeliac disease and hypogonadism
- FRAX estimates ten-year fracture probability from clinical factors, with or without a DEXA result
Applied Aspects
- Prevention begins in adolescence by building peak bone mass — adequate calcium and vitamin D, and weight-bearing exercise
- Bisphosphonates inhibit osteoclasts and are first-line; watch for oesophagitis, and rarely osteonecrosis of the jaw and atypical femoral fracture
- Other agents — denosumab (an anti-RANKL antibody), teriparatide (recombinant PTH, which is anabolic), and selective oestrogen receptor modulators
- Anyone on long-term corticosteroids needs bone protection from the start, not after a fracture — steroid-induced loss is fastest in the first months
- Falls prevention matters as much as bone density — reviewing sedatives, correcting vision, treating postural hypotension and removing home hazards
- Osteoporosis is under-recognised in India, occurs at a younger age than in the West, and coexists with widespread vitamin D deficiency — correcting the latter is cheap and should be routine
All questions in Endocrine, Bone & Breast Pathology
- Q1Classify diabetes mellitus. Differentiate type 1 from type 2 and describe the pathogenesis, morphology of complications and acute metabolic emergencies. ★
- Q2Classify thyroid disorders. Describe Graves disease, Hashimoto thyroiditis and the carcinomas of the thyroid. ★
- Q3Describe Cushing syndrome with its causes and investigation. Add notes on adrenal insufficiency, phaeochromocytoma and pituitary disorders. ★
- Q4Classify breast lesions. Describe the risk factors, classification, morphology and prognostic factors of breast carcinoma. ★
- Q5Describe the metabolic bone diseases. Add notes on osteomyelitis and the classification and features of bone tumours. ★
- SN1Describe the multiple endocrine neoplasia syndromes. ★
- SN2Define osteoporosis. Describe its causes, pathogenesis and diagnosis. ★
- SN3Describe fibroadenoma of the breast and differentiate it from a phyllodes tumour. ★
- SN4Define goitre. Describe the causes and pathogenesis of simple and multinodular goitre. ★
- SN5Describe carcinoma of the cervix with its aetiology, precursor lesions and prevention. ★
- SN6Describe gestational trophoblastic disease. Differentiate complete from partial mole and add a note on choriocarcinoma.
- SN7Describe hypothyroidism and hyperthyroidism with their causes, features and the interpretation of thyroid function tests. ★